Home > Healthcare > Healthcare IT > ambulatory surgical centers market
Get a free sample of Ambulatory Surgical Centers Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Get a free sample of Ambulatory Surgical Centers Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
The ambulatory surgical centers industry is fragmented, with various large multinationals and small to mid-sized companies competing. The development and launch of new services are key market strategies for ambulatory surgical centers service providers, driving competition and innovation within the industry. This emphasis on innovation aims to address evolving needs and enhance patient outcomes, positioning companies to gain market share and meet the growing demand for advanced ambulatory surgical centers and services.
Some of the eminent market participants operating in the ambulatory surgical centers industry include:
North America ambulatory surgical centers industry accounted for USD 40.6 billion in 2023 and is predicted to witness substantial growth through 2032, due to the adoption of minimally invasive surgical techniques, such as robotic-assisted surgeries and laparoscopic procedures.
HCA Healthcare, Physicians Endoscopy, Pinnacle III, Proliance Surgeons, Regent Surgical Health, SCA Health (Unitedhealth Group Incorporated), and SurgCenter Development among others.
The global ambulatory surgical centers industry was valued at around USD 93.8 billion in 2023 and is expected to record a CAGR of 4.8% through 2032, due to the increasing geriatric population and prevalence of chronic diseases worldwide.
The opthalmology segment is anticipated to be worth 36.8 billion by 2032 as these surgeries typically have short procedure times and allow for quick recovery, making them well-suited for the outpatient setting of ASCs, where efficiency and quick turnover are key.